Skip to content

ILMN

Monitor

Illumina Inc

$205.09+10.27 (+5.27%)
Eldercare
Quality50/100

research_scan theme='biotech-genomics'; value_chain_position='upstream-enabler'; Dominant short-read sequencing platform (~70% global share inferring); the upstream-enabler that sells into every modality. Most exposed to commoditisation in the value chain per prior scan — share loss to PacBio / Oxford Nanopore in long-read, and price-per-genome pressure from BGI/MGI under BIOSECURE Act carve-outs.

Full research is one sign-in away

  • Verdict + reasoning
  • Falsification triggers
  • Financials
  • Price history
Sign in

General, impersonal research — never personalized advice.